{"entity":{"type":"insider","cik":"0001810882","url":"/insider/0001810882","json_url":"/insider/0001810882.json","name":"Lebwohl David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":10,"first":"2021-08-11","last":"2026-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Lebwohl David","source":"filing","n_filings":10,"first_seen":"2021-08-11","last_seen":"2026-01-07"}],"transactions":[{"id":5846744,"accession":"0001193125-26-006283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006283","line_url":"/filing/0001193125-26-006283#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11903.0,"shares_display":"11,903","price_per_share":9.21,"price_display":"9.21","price_state":"stated","total_value":109626.63,"total_display":"109,626.63","total_whole":"109,627","shares_owned_after":121249.0,"shares_owned_after_display":"121,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4939616,"accession":"0000950170-25-003015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-003015","line_url":"/filing/0000950170-25-003015#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9557.0,"shares_display":"9,557","price_per_share":12.18,"price_display":"12.18","price_state":"stated","total_value":116404.26,"total_display":"116,404.26","total_whole":"116,404","shares_owned_after":87666.0,"shares_owned_after_display":"87,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"},{"id":2139869,"accession":"0000950170-24-002515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-002515","line_url":"/filing/0000950170-24-002515#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5843.0,"shares_display":"5,843","price_per_share":29.46,"price_display":"29.46","price_state":"stated","total_value":172134.78,"total_display":"172,134.78","total_whole":"172,135","shares_owned_after":54372.0,"shares_owned_after_display":"54,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8435289,"accession":"0001209191-23-002417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002417","line_url":"/filing/0001209191-23-002417#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2574.0,"shares_display":"2,574","price_per_share":37.21,"price_display":"37.21","price_state":"stated","total_value":95778.54,"total_display":"95,778.54","total_whole":"95,779","shares_owned_after":25687.0,"shares_owned_after_display":"25,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6652120,"accession":"0001209191-22-015960","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015960","line_url":"/filing/0001209191-22-015960#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1051.0,"shares_display":"1,051","price_per_share":112.24,"price_display":"112.24","price_state":"stated","total_value":117964.24,"total_display":"117,964.24","total_whole":"117,964","shares_owned_after":10922.0,"shares_owned_after_display":"10,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-01","filed_date":"2022-03-03","scope":"insider"},{"id":5299272,"accession":"0001209191-21-063698","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-063698","line_url":"/filing/0001209191-21-063698","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":132.72275,"price_display":"132.72","price_state":"stated","total_value":318534.6,"total_display":"318,534.60","total_whole":"318,535","shares_owned_after":9914.0,"shares_owned_after_display":"9,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-09","scope":"insider","n_lines":4},{"id":4741483,"accession":"0001209191-21-060638","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-060638","line_url":"/filing/0001209191-21-060638","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":128.43712916666667,"price_display":"128.44","price_state":"stated","total_value":308249.11,"total_display":"308,249.11","total_whole":"308,249","shares_owned_after":9714.0,"shares_owned_after_display":"9,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-15","scope":"insider","n_lines":5},{"id":4956139,"accession":"0001209191-21-057475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057475","line_url":"/filing/0001209191-21-057475#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":149.81,"price_display":"149.81","price_state":"stated","total_value":359544.0,"total_display":"359,544.00","total_whole":"359,544","shares_owned_after":791.0,"shares_owned_after_display":"791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-23","scope":"insider"},{"id":4385028,"accession":"0001209191-21-054317","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-054317","line_url":"/filing/0001209191-21-054317","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":158.04166666666666,"price_display":"158.04","price_state":"stated","total_value":379300.0,"total_display":"379,300.00","total_whole":"379,300","shares_owned_after":941.0,"shares_owned_after_display":"941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-30","filed_date":"2021-09-01","scope":"insider","n_lines":5},{"id":4485463,"accession":"0001209191-21-050881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-050881","line_url":"/filing/0001209191-21-050881#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001810882","owner_name":"Lebwohl David","owner_display_name":"Lebwohl David","owner_url":"/insider/0001810882","role":"Officer (EVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":164.05,"price_display":"164.05","price_state":"stated","total_value":393720.0,"total_display":"393,720.00","total_whole":"393,720","shares_owned_after":791.0,"shares_owned_after_display":"791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Officer (EVP, Chief Medical Officer)","n_filings":10,"first_seen":"2021-08-11","last_seen":"2026-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001810882","retrieved_at":"2026-08-27T06:36:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}